ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

What's Up With These Ridiculous Stock Gains?

Steve Reitmeister didn't want me to tell you this. He felt that one strategy's performance stands out so much that... Read on >>

Quote:

Search for Ticker

Free Membership

Search:

ODSY: Odyssey Healthcare Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

ODYSSEY HEALTHCARE INC (NASD)
ODSY	15.20	-0.15	(-0.98%)	Vol. 301,642	16:00 ET

Odyssey Healthcare, Inc. one of the largest providers of hospice care in the United States. Hospice services focus on palliative care for patients with life-limiting illnesses, which is care directed at managing pain and other discomforting symptoms and addressing the psychosocial and spiritual needs of patients and their families.

General Information

ODYSSEY HLTHCR

717 N. Harwood Suite 1500 Dallas, TX 75201 Phone: 214 922-9711 Fax: 214 922-9752 Web: www.odsyhealth.com Email: info@odsyhealth.com

Industry	MED-OUTP/HM CRE
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/17/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	15.35
52 Week High	15.50
52 Week Low	7.00
Beta	0.60
20 Day Moving Average	274,187.25
Target Price Consensus	16.5

% Price Change
4 Week	21.07
12 Week	13.90
YTD	62.16

% Price Change Relative to S&P 500
4 Week	19.76
12 Week	7.38
YTD	34.21

Share Information
Shares Outstanding (millions)	32.94
Market Capitalization (millions)	494.04
Short Ratio	8.33
Last Split Date	08/13/2003

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.30
Current Year EPS Consensus Estimate	1.19
Estimated Long-Term EPS Growth Rate	13.50
Next EPS Report Date	02/17/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.14
30 Days Ago	2.25
60 Days Ago	2.25
90 Days Ago	2.33

Fundamental Ratios

P/E
Current FY Estimate:	12.65
Trailing 12 Months:	14.15
PEG Ratio	0.94

EPS Growth
vs. Previous Year	84.21%
vs. Previous Quarter	29.63%

Sales Growth
vs. Previous Year	6.05%
vs. Previous Quarter:	2.90%

Price Ratios
Price/Book	2.11
Price/Cash Flow	17.30
Price / Sales	0.73

ROE
09/30/09	16.18
06/30/09	14.37
03/31/09	12.51

ROA
09/30/09	7.47
06/30/09	6.39
03/31/09	5.37

Current Ratio
09/30/09	1.71
06/30/09	1.72
03/31/09	1.80

Quick Ratio
09/30/09	1.71
06/30/09	1.72
03/31/09	1.80

Operating Margin
09/30/09	5.16
06/30/09	4.44
03/31/09	3.76

Net Margin
09/30/09	8.29
06/30/09	7.05
03/31/09	5.97

Pre-Tax Margin
09/30/09	8.29
06/30/09	7.05
03/31/09	5.97

Book Value
09/30/09	7.12
06/30/09	6.74
03/31/09	6.45

Inventory Turnover
09/30/09	-
06/30/09	-
03/31/09	-

Debt-to-Equity
09/30/09	0.38
06/30/09	0.46
03/31/09	0.54

Debt to Capital
09/30/09	27.54
06/30/09	31.31
03/31/09	35.20


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research